Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SABA
3651
Saba Capital Income & Opportunities Fund II
SABA
$255M
| $152K | ﹤0.01% |
16,591
-14,587
| -47% | -$134K |
|
|
BIOA
3652
BioAge Labs, Inc. Common Stock
BIOA
$173M
| $149K | ﹤0.01% |
+36,073
| New | +$149K |
|
3653
X4 Pharmaceuticals
XFOR
$76.1M
| $148K | ﹤0.01% |
78,061
+69,436
| +805% | +$132K |
|
3654
DMC Global
BOOM
$141M
| $148K | ﹤0.01% |
18,347
-136,869
| -88% | -$1.1M |
|
3655
Strawberry Fields REIT
STRW
$150M
| $147K | ﹤0.01% |
+13,951
| New | +$147K |
|
3656
BlackRock Floating Rate Income Trust
BGT
$343M
| $146K | ﹤0.01% |
11,686
-23,846
| -67% | -$299K |
|
3657
Kopin
KOPN
$344M
| $145K | ﹤0.01% |
95,006
-2,057,484
| -96% | -$3.15M |
|
|
KLRS
3658
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.1M
| $144K | ﹤0.01% |
54,092
+37,510
| +226% | +$100K |
|
3659
Sasol
SSL
$4.54B
| $144K | ﹤0.01% |
32,510
-1,417,845
| -98% | -$6.27M |
|
|
NTHI
3660
NeOnc Technologies Holdings, Inc. Common Stock
NTHI
$191M
| $144K | ﹤0.01% |
+40,248
| New | +$144K |
|
3661
Crawford & Co Class A
CRD.A
$513M
| $143K | ﹤0.01% |
13,519
+1,390
| +11% | +$14.7K |
|
3662
Trinseo
TSE
$81.6M
| $139K | ﹤0.01% |
44,624
-227,884
| -84% | -$711K |
|
3663
LG Display
LPL
$4.33B
| $138K | ﹤0.01% |
+40,482
| New | +$138K |
|
3664
SharpLink Gaming
SBET
$3.12B
| $138K | ﹤0.01% |
+13,937
| New | +$138K |
|
3665
AdaptHealth
AHCO
$1.24B
| $138K | ﹤0.01% |
14,672
-65,727
| -82% | -$620K |
|
|
ORKA
3666
Oruka Therapeutics, Inc. Common Stock
ORKA
$591M
| $138K | ﹤0.01% |
12,326
-41,800
| -77% | -$469K |
|
|
HITI
3667
High Tide
HITI
$286M
| $138K | ﹤0.01% |
59,949
+32,609
| +119% | +$75K |
|
|
FBRT
3668
Franklin BSP Realty Trust
FBRT
$953M
| $137K | ﹤0.01% |
+12,858
| New | +$137K |
|
3669
Karyopharm Therapeutics
KPTI
$53.8M
| $137K | ﹤0.01% |
31,847
-23,520
| -42% | -$101K |
|
3670
Playboy, Inc. Common Stock
PLBY
$197M
| $137K | ﹤0.01% |
84,554
-146,133
| -63% | -$237K |
|
3671
Fennec Pharmaceuticals
FENC
$251M
| $136K | ﹤0.01% |
+16,334
| New | +$136K |
|
3672
Destination XL Group
DXLG
$67.9M
| $134K | ﹤0.01% |
120,807
+89,106
| +281% | +$98.9K |
|
3673
Invesco Trust Investment Grade Municipals
VGM
$542M
| $133K | ﹤0.01% |
+14,000
| New | +$133K |
|
3674
Golden Matrix Group
GMGI
$133M
| $133K | ﹤0.01% |
+78,109
| New | +$133K |
|
3675
Envela
ELA
$186M
| $131K | ﹤0.01% |
21,412
-58,057
| -73% | -$355K |
|